Skip to main content
SpringerLink
Log in

Bevacizumab

Reversible posterior leukoencephalopathy syndrome: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Allen JA, Adlakha A, Bergethon PR.Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Archives of Neurology 63: 1475-1478, No. 10, Oct 2006 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab. React. Wkly. 1128, 8 (2006). https://doi.org/10.2165/00128415-200611280-00025

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611280-00025

Keywords

Search

Navigation